Reply to: "Comment on 'Incidence of pneumocystosis among patients exposed to immunosuppression'"

J Am Acad Dermatol. 2019 Aug;81(2):e49-e50. doi: 10.1016/j.jaad.2019.03.072. Epub 2019 Mar 30.

Authors

Sergey Rekhtman¹, Andrew Strunk¹, Amit Garg²

Affiliations

¹ Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
² Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York. Electronic address: amgarg@northwell.edu.

PMID: 30940510
DOI: 10.1016/j.jaad.2019.03.072

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Immune Tolerance
Immunologic Deficiency Syndromes*
Immunosuppression Therapy
Incidence
Pneumonia, Pneumocystis*